Search

Search Constraints

You searched for: Author/Creator Hoffman, R.

Search Results

1. A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-­polycythemia vera/essential thrombocythemia myelofibrosis (post-­PV/ET MF). (January 2020)

2. ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis. (October 2022)

6. European General Practice Research Network (EGPRN). (March 2014)

8. Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase. (May 1997)